Cargando…
Heparan sulfate proteoglycans and their modification as promising anticancer targets in hepatocellular carcinoma
Hepatocellular carcinoma (HCC) is one of the most common types of primary liver cancer. Despite advancements in the treatment strategies of HCC, there is an urgent requirement to identify and develop novel therapeutic drugs that do not lead to resistance. These novel agents should have the potential...
Autores principales: | Alshehri, Mohammed A., Alshehri, Moath M., Albalawi, Naif N., Al-Ghamdi, Moshari A., Al-Gayyar, Mohammed M.H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798035/ https://www.ncbi.nlm.nih.gov/pubmed/33552290 http://dx.doi.org/10.3892/ol.2021.12434 |
Ejemplares similares
-
Heparan Sulfate and Heparan Sulfate Proteoglycans in Cancer Initiation and Progression
por: Nagarajan, Arvindhan, et al.
Publicado: (2018) -
Heparan sulfate proteoglycans and cancer
por: Blackhall, F H, et al.
Publicado: (2001) -
Heparan Sulfate Proteoglycans in Infection
por: Bartlett, Allison H., et al.
Publicado: (2011) -
Heparan Sulfate Proteoglycans in Tauopathy
por: Zhu, Yanan, et al.
Publicado: (2022) -
Galectin-14 promotes hepatocellular carcinoma tumor growth
via enhancing heparan sulfate proteoglycan modification
por: Gou, Liming, et al.
Publicado: (2023)